Back to search results

Acupuncture for Chronic Pelvic Pain Study

This study is looking at whether a specific type of acupuncture, called the "Dragons protocol," can help reduce chronic (long-lasting) pelvic pain in women. This research focuses on women aged 21-65 who have chronic pelvic pain not caused by endometriosis, including those with or without a history of sexual assault. The study will compare the Dragons acupuncture treatment to standard care therapies like physical therapy. Researchers will measure your pain levels using the Defense and Veterans Pain Rating Scale (DVPRS) at the beginning, after four weeks, and after five weeks to see if acupuncture helps reduce pain intensity. The goal is to find out if acupuncture could be an affordable alternative for managing this type of pain.

Study design
This interventional study plans to enroll 64 women. It compares the Dragons acupuncture protocol to standard care therapies.
What's involved
You would receive acupuncture treatment with the Dragons protocol. You would also have your pain levels measured at three different visits over five weeks.
Compensation
Not stated in the trial record.
Follow-up
Your pain levels will be measured at the start of the study, after 4 weeks, and after 5 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06388590

Acupuncture for Chronic Pelvic Pain

Recruiting
NAAges 21–65InterventionalTreatment
David Moss
~64 participants
Updated 2026-04-14 on ClinicalTrials.gov
What's tested:DragonsStandard of Care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Defense and Veterans Pain Rating Scale (DVPRS)
Measured over Visit 1 (Week 0)
+11 more outcomes measured

Conditions

Pelvic Pain
Acupuncture
Gynecology

Explore related trials

Pelvic Pain

Where it's being run

1 sites across 1 states
Nevada1

Who to contact

Amanda Crawford, MSHS
[email protected]
7026533583
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Active Duty and DoD Female Beneficiaries (i.e. former military, spouse, dependent) aged 21-65 with chronic pelvic pain
Have negative laparoscopic findings for endometriosis

Exclusion

Severe mental health disorders to include any disorder with psychotic features (e.g schizophrenia, bipolar, schizoaffective disorder)
Pelvic pain as a result of severe physical trauma (excluding sexual assault) such as traumatic childbirth, pelvic fractures or any other trauma as determined by the PI or AI.
Pregnancy

What this trial measures

  • Defense and Veterans Pain Rating Scale (DVPRS)Visit 1 (Week 0)

    The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.

  • Defense and Veterans Pain Rating Scale (DVPRS)Visit 2 (Week 4)

    The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.

  • Defense and Veterans Pain Rating Scale (DVPRS)Visit 3 (Week 5)

    The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.

  • Defense and Veterans Pain Rating Scale (DVPRS)Visit 4 (Week 6)

    The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.

  • Defense and Veterans Pain Rating Scale (DVPRS)Visit 5 (Week 7)

    The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.

  • Defense and Veterans Pain Rating Scale (DVPRS)Visit 6 (Week 11)

    The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.

  • Female Genitourinary Pain Index (GUPI)Visit 1 (Week 0)

    GUPI is a validated instrument to assess the degree of symptoms in both men and women with genitourinary pain complaints. It has a range of 0 to 45 and has also demonstrated linear scale qualities allowing parametric methods to be used.

  • Female Genitourinary Pain Index (GUPI)Visit 2 (Week 4)

    GUPI is a validated instrument to assess the degree of symptoms in both men and women with genitourinary pain complaints. It has a range of 0 to 45 and has also demonstrated linear scale qualities allowing parametric methods to be used.

  • Female Genitourinary Pain Index (GUPI)Visit 3 (Week 5)

    GUPI is a validated instrument to assess the degree of symptoms in both men and women with genitourinary pain complaints. It has a range of 0 to 45 and has also demonstrated linear scale qualities allowing parametric methods to be used.

  • Female Genitourinary Pain Index (GUPI)Visit 4 (Week 6)

    GUPI is a validated instrument to assess the degree of symptoms in both men and women with genitourinary pain complaints. It has a range of 0 to 45 and has also demonstrated linear scale qualities allowing parametric methods to be used.

  • Female Genitourinary Pain Index (GUPI)Visit 5 (Week 7)

    GUPI is a validated instrument to assess the degree of symptoms in both men and women with genitourinary pain complaints. It has a range of 0 to 45 and has also demonstrated linear scale qualities allowing parametric methods to be used.

  • Female Genitourinary Pain Index (GUPI)Visit 6 (Week 11)

    GUPI is a validated instrument to assess the degree of symptoms in both men and women with genitourinary pain complaints. It has a range of 0 to 45 and has also demonstrated linear scale qualities allowing parametric methods to be used.